AI assistant
Sending…
Cue Biopharma, Inc. — Director's Dealing 2017
Dec 27, 2017
34525_dirs_2017-12-27_61c1b85c-0e32-4320-b281-78ba1aab79ac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cue Biopharma, Inc. (CUE)
CIK: 0001645460
Period of Report: 2017-12-18
Reporting Person: SCHUMAN GARY ALAN (Interim CFO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 66750 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants | $2.70 | 2022-06-15 | Common Stock (11111) | Direct |
More from Cue Biopharma, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 3
Regulatory Filings
2026
Jun 3
Regulatory Filings
2026
Jun 3
Board/Management Information
2026
Jun 2
Proxy Solicitation & Information Statement
2026
May 21
Report Publication Announcement
2026
May 14
Interim / Quarterly Report
2026
May 14
Capital/Financing Update
2026
Apr 22
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 13
Regulatory Filings
2026
Apr 7